IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$329M
AUM Growth
-$29.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
77
New
Increased
Reduced
Closed

Top Buys

1
+$12.2M
2
+$8.46M
3
+$7.07M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.94M
5
GILD icon
Gilead Sciences
GILD
+$6.94M

Top Sells

1
+$40.5M
2
+$16.7M
3
+$10.5M
4
QURE icon
uniQure
QURE
+$8.77M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$8.53M

Sector Composition

1 Healthcare 99.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCM icon
51
HUTCHMED
HCM
$2.42B
$816K 0.25%
68,000
BEAM icon
52
Beam Therapeutics
BEAM
$2.58B
$750K 0.23%
23,500
PTCT icon
53
PTC Therapeutics
PTCT
$5.55B
$692K 0.21%
17,000
-76,000
AGIO icon
54
Agios Pharmaceuticals
AGIO
$1.65B
$680K 0.21%
+24,000
PTGX icon
55
Protagonist Therapeutics
PTGX
$6.2B
$549K 0.17%
+19,900
AMLX icon
56
Amylyx Pharmaceuticals
AMLX
$1.52B
$539K 0.16%
+25,000
VTYX
57
DELISTED
Ventyx Biosciences
VTYX
$491K 0.15%
15,000
IOVA icon
58
Iovance Biotherapeutics
IOVA
$1.55B
$457K 0.14%
65,000
+9,000
ARVN icon
59
Arvinas
ARVN
$697M
$421K 0.13%
17,000
QURE icon
60
uniQure
QURE
$921M
$178K 0.05%
15,500
-463,000
RLMD icon
61
Relmada Therapeutics
RLMD
$455M
$24.7K 0.01%
10,000
ACET icon
62
Adicet Bio
ACET
$66.5M
– –
-9,669
ALKS icon
63
Alkermes
ALKS
$4.53B
– –
-593,000
ASND icon
64
Ascendis Pharma
ASND
$14B
– –
-29,400
AZN icon
65
AstraZeneca
AZN
$292B
– –
-65,000
BCRX icon
66
BioCryst Pharmaceuticals
BCRX
$2.3B
– –
-57,000
CRBU icon
67
Caribou Biosciences
CRBU
$185M
– –
-457,892
CRSP icon
68
CRISPR Therapeutics
CRSP
$4.58B
– –
-34,200
EXEL icon
69
Exelixis
EXEL
$10.7B
– –
-543,000
GMAB icon
70
Genmab
GMAB
$15.9B
– –
-88,000
IDYA icon
71
IDEAYA Biosciences
IDYA
$2.93B
– –
-19,000
IRWD icon
72
Ironwood Pharmaceuticals
IRWD
$517M
– –
-60,000
NVAX icon
73
Novavax
NVAX
$1.63B
– –
-132,500
SNY icon
74
Sanofi
SNY
$106B
– –
-143,500
SGEN
75
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-200,200
1 2
3
4